Author: afnhi

The world still needs a safe, effective, affordable and accessible HIV Vaccine
despite disruptions by COVID 19,

HIV Vaccine Awareness Day (HVAD) is observed today, the 18th of May to recognize the many volunteers, community members, health professionals, and scientists working to develop a safe, accessible, affordable and effective preventive HIV vaccine key to ending the HIV and AIDS epidemic. HVAD is also an opportunity to educate communities about the importance of […]

COVID 19 AND LACK OF FUNDING NEGATING GAINS HIV PROGRESS

Stakeholders have warned that COVID 19 disruptions are likely to set back efforts made in curbing HIV infections back to ten years or more. According to UNAIDS’ new report released in July 2020, while securing antiretroviral therapy has been steadily improving, the progress is inequitable. In its report, Seizing the moment, the World Bank warns […]

HIV Vaccine Research A community and civil society perspective, and commentary on HVTN 702

Background: On 3rd February 2020, the US National Institute of Allergy and Infectious Diseases (NIAID) announced that HVTN 702, a large-scale HIV vaccine efficacy trial of a vaccine candidate, has stopped vaccinations because the vaccine does not prevent HIV. The trial, conducted at 14 sites across South Africa, followed more than 5400 HIV-negative 18–35-year-olds over […]

AfNHi Celebrates Dr. Manasseh Phiri

On Monday 22nd April 2019, AfNHi, an African led network of HIV prevention research advocates, learnt with a great sense of loss, that Dr Manasseh Phiri is no more. Dr Manasseh, fondly referred to as ‘Papa’ by his AfNHi family, is a founder member of AfNHi and has diligently served as a steering committee member […]

NPT Capacity Building Interests among African Civil Society Advocates

Background: The Africa Free of New HIV Infections (AfNHi) commissioned an assessment in order to map national level organisations undertaking biomedical HIV prevention research advocacy, or that have an interest therein. Opportunities and enablers for an expanded African led civil society network driving biomedical HIV prevention research advocacy were explored. Methods: Organisations were identified through […]

Environmental enablers for implementing biomedical HIV prevention research advocacy

Background: The Africa Free of New HIV Infections (AfNHi) commissioned an assessment in order to map national level organisations undertaking biomedical HIV prevention research advocacy, or that have an interest therein. Opportunities and enablers for an expanded African led civil society network driving biomedical HIV prevention research advocacy were explored. Methods: Organisations were identified through […]

African-Led Civil Society Network Characteristics

Background: The Africa Free of New HIV Infections (AfNHi) commissioned an assessment in order to map national level organisations undertaking biomedical HIV prevention research advocacy, or that have an interest therein. Opportunities and enablers for an expanded African led civil society network driving biomedical HIV prevention research advocacy were explored. Methods: Organisations were identified through […]

Advocacy Experiences by Steering Commitee

The section below provides in-country reflections from AfNHi steering committee members on doing HIV prevention research advocacy, as well as looking ahead as AfNHi into what might be needed to champion civil society advocacy in the future. Alice, UgandaMaureen, Malawi Morenike, NigeriaSydney, GhanaNtando, South AfricaRosemary, KenyaAlice, Uganda While there is some level of consultation at [...]